TMS for CRPS - Pilot Study
- Conditions
- Complex Regional Pain Syndrome (CRPS)
- Interventions
- Device: Transcranial Magnetic Stimulation
- Registration Number
- NCT01926119
- Lead Sponsor
- Stanford University
- Brief Summary
The purpose of this pilot study is to test whether Transcranial Magnetic Stimulation (TMS) may alleviate the symptoms of Complex Regional Pain Syndrome (CRPS). The investigators will test various methods of TMS in a small pilot study to investigate what methods may have clinical potential. This is a small pilot study to determine feasibility and signal to potentially inform future trials.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 4
- Age 18 or older
- Diagnosis of CRPS (complex regional pain syndrome)
- Average pain level reported on Numerical Rating Scale meets entry criteria
- Ability to perform the experimental task and procedures.
- MRI contraindication (metal implants or devices, claustrophobia)
- TMS Contraindication (eg metal implant or devices near the site of stimulation)
- History of epilepsy
- History of a psychological or psychiatric disorder that would interfere with study procedures, at the discretion of the researcher.
- Neurologic illness that would interfere with brain integrity
- Current medical condition or medication use that would interfere with study procedures or data integrity, at the discretion of the researcher.
- Currently pregnant or planning to become pregnant.
- On going legal action or disability claim.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description TMS Intervention - 5 days Transcranial Magnetic Stimulation Application of Transcranial Magnetic Stimulation (TMS) once per day over 5 days.
- Primary Outcome Measures
Name Time Method Change in Pain Baseline to post-TMS day 5 Numerical rating scale (NRS) where 0=no pain and 10=worst pain imaginable
- Secondary Outcome Measures
Name Time Method Change in Sudomotor Function End of each treatment session and at 1-week follow-up as compared to baseline Change in Vasomotor Function End of each treatment session and at 1-week follow-up as compared to baseline Change in Sensory Perception End of each treatment session and at 1-week follow-up as compared to baseline Trophic Changes End of each treatment session and at 1-week follow-up as compared to baseline Change in Motor Function and Coordination End of 5-day treatment series and at 1-week follow-up relative to baseline As assessed by functional capacity exam and physical exam
Change in Motor Strength and Joint Range of Motion End of each of the 5 treatment sessions and at 1-week follow-up relative to baseline
Trial Locations
- Locations (1)
Stanford University School of Medicine
🇺🇸Palo Alto, California, United States